Article
Adult T-cell leukemia/lymphoma triggered by adalimumab.
Registro en:
BITTENCOURT, A. C. L. et al. Adult T-cell leukemia/lymphoma triggered by adalimumab. Journal of Clinical Virology, v. 58, n. 2, p. 494-966, 2013.
1873-5967
dx.doi.org/10.1016/j.jcv.2013.07.011
Autor
Bittencourt, Achilea Candida Lisboa
Oliveira, Pedro Dantas
Bittencourt, Valeria Gusmão
Carvalho Filho, Edgar Marcelino
Vallve, Maria de Lourdes Farre
Resumen
Here, we describe a 48-year-old woman infected by the human T-cell lymphotropic virus type 1 (HTLV-1) with spondyloarthritis, uveitis, bilateral episcleritis and neurogenic bladder. She had a history of a probable infective dermatitis associated with HTLV-1 (IDH) in childhood. After the use of adalimumab, she developed lymphocytosis and a cutaneous lymphoma associated with IDH. She had the diagnoses of IDH and of chronic adult T-cell leukemia/lymphoma, supported by the demonstration of proviral integration in the cutaneous lesion.